 | • レポートコード：QY2203B05354 • 出版社/出版日：QYResearch / 2022年3月25日 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のフェニルケトン尿症治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフェニルケトン尿症治療薬の世界市場のxxx％を占める「医薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「家庭用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のフェニルケトン尿症治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフェニルケトン尿症治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフェニルケトン尿症治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 フェニルケトン尿症治療薬のグローバル主要メーカーには、Biomarin、Vitaflo、Mead Johnson、Nutricia、Abbott、Dr. Schar、Prominmetabolics、Cambrooke、Juvela、Firstplay Dietaryなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フェニルケトン尿症治療薬市場は、種類と用途によって区分されます。世界のフェニルケトン尿症治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 医薬品、サプリメント、その他 【用途別セグメント】 家庭用、病院用、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フェニルケトン尿症治療薬製品概要 - 種類別市場（医薬品、サプリメント、その他） - 用途別市場（家庭用、病院用、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフェニルケトン尿症治療薬販売量予測2017-2028 - 世界のフェニルケトン尿症治療薬売上予測2017-2028 - フェニルケトン尿症治療薬の地域別販売量 - フェニルケトン尿症治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フェニルケトン尿症治療薬販売量 - 主要メーカー別フェニルケトン尿症治療薬売上 - 主要メーカー別フェニルケトン尿症治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（医薬品、サプリメント、その他） - フェニルケトン尿症治療薬の種類別販売量 - フェニルケトン尿症治療薬の種類別売上 - フェニルケトン尿症治療薬の種類別価格 ・用途別市場規模（家庭用、病院用、その他） - フェニルケトン尿症治療薬の用途別販売量 - フェニルケトン尿症治療薬の用途別売上 - フェニルケトン尿症治療薬の用途別価格 ・北米市場 - 北米のフェニルケトン尿症治療薬市場規模（種類別、用途別） - 主要国別のフェニルケトン尿症治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフェニルケトン尿症治療薬市場規模（種類別、用途別） - 主要国別のフェニルケトン尿症治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフェニルケトン尿症治療薬市場規模（種類別、用途別） - 主要国別のフェニルケトン尿症治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフェニルケトン尿症治療薬市場規模（種類別、用途別） - 主要国別のフェニルケトン尿症治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフェニルケトン尿症治療薬市場規模（種類別、用途別） - 主要国別のフェニルケトン尿症治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Biomarin、Vitaflo、Mead Johnson、Nutricia、Abbott、Dr. Schar、Prominmetabolics、Cambrooke、Juvela、Firstplay Dietary ・産業チェーン及び販売チャネル分析 - フェニルケトン尿症治療薬の産業チェーン分析 - フェニルケトン尿症治療薬の原材料 - フェニルケトン尿症治療薬の生産プロセス - フェニルケトン尿症治療薬の販売及びマーケティング - フェニルケトン尿症治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フェニルケトン尿症治療薬の産業動向 - フェニルケトン尿症治療薬のマーケットドライバー - フェニルケトン尿症治療薬の課題 - フェニルケトン尿症治療薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Phenylketonuria Drug Market
Due to the COVID-19 pandemic, the global Phenylketonuria Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Medications accounting for % of the Phenylketonuria Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Household segment is altered to an % CAGR throughout this forecast period.
China Phenylketonuria Drug market size is valued at US$ million in 2021, while the US and Europe Phenylketonuria Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Phenylketonuria Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Phenylketonuria Drug include Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Schar, Prominmetabolics, Cambrooke and Juvela and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Phenylketonuria Drug Scope and Segment
Phenylketonuria Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Phenylketonuria Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medications
Supplements
Others
Segment by Application
Household
Hospital
Others
By Company
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Dr. Schar
Prominmetabolics
Cambrooke
Juvela
Firstplay Dietary
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Phenylketonuria Drug Product Introduction
1.2 Market by Type
1.2.1 Global Phenylketonuria Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medications
1.2.3 Supplements
1.2.4 Others
1.3 Market by Application
1.3.1 Global Phenylketonuria Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Household
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Phenylketonuria Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Phenylketonuria Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Phenylketonuria Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Phenylketonuria Drug Sales by Region
2.4.1 Global Phenylketonuria Drug Sales by Region (2017-2022)
2.4.2 Global Sales Phenylketonuria Drug by Region (2023-2028)
2.5 Global Phenylketonuria Drug Revenue by Region
2.5.1 Global Phenylketonuria Drug Revenue by Region (2017-2022)
2.5.2 Global Phenylketonuria Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Phenylketonuria Drug Sales by Manufacturers
3.1.1 Global Top Phenylketonuria Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Phenylketonuria Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Phenylketonuria Drug in 2021
3.2 Global Phenylketonuria Drug Revenue by Manufacturers
3.2.1 Global Phenylketonuria Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Phenylketonuria Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Phenylketonuria Drug Revenue in 2021
3.3 Global Phenylketonuria Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Phenylketonuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Phenylketonuria Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Phenylketonuria Drug Sales by Type
4.1.1 Global Phenylketonuria Drug Historical Sales by Type (2017-2022)
4.1.2 Global Phenylketonuria Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Phenylketonuria Drug Sales Market Share by Type (2017-2028)
4.2 Global Phenylketonuria Drug Revenue by Type
4.2.1 Global Phenylketonuria Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Phenylketonuria Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
4.3 Global Phenylketonuria Drug Price by Type
4.3.1 Global Phenylketonuria Drug Price by Type (2017-2022)
4.3.2 Global Phenylketonuria Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Phenylketonuria Drug Sales by Application
5.1.1 Global Phenylketonuria Drug Historical Sales by Application (2017-2022)
5.1.2 Global Phenylketonuria Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Phenylketonuria Drug Sales Market Share by Application (2017-2028)
5.2 Global Phenylketonuria Drug Revenue by Application
5.2.1 Global Phenylketonuria Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Phenylketonuria Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
5.3 Global Phenylketonuria Drug Price by Application
5.3.1 Global Phenylketonuria Drug Price by Application (2017-2022)
5.3.2 Global Phenylketonuria Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Phenylketonuria Drug Market Size by Type
6.1.1 North America Phenylketonuria Drug Sales by Type (2017-2028)
6.1.2 North America Phenylketonuria Drug Revenue by Type (2017-2028)
6.2 North America Phenylketonuria Drug Market Size by Application
6.2.1 North America Phenylketonuria Drug Sales by Application (2017-2028)
6.2.2 North America Phenylketonuria Drug Revenue by Application (2017-2028)
6.3 North America Phenylketonuria Drug Market Size by Country
6.3.1 North America Phenylketonuria Drug Sales by Country (2017-2028)
6.3.2 North America Phenylketonuria Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Phenylketonuria Drug Market Size by Type
7.1.1 Europe Phenylketonuria Drug Sales by Type (2017-2028)
7.1.2 Europe Phenylketonuria Drug Revenue by Type (2017-2028)
7.2 Europe Phenylketonuria Drug Market Size by Application
7.2.1 Europe Phenylketonuria Drug Sales by Application (2017-2028)
7.2.2 Europe Phenylketonuria Drug Revenue by Application (2017-2028)
7.3 Europe Phenylketonuria Drug Market Size by Country
7.3.1 Europe Phenylketonuria Drug Sales by Country (2017-2028)
7.3.2 Europe Phenylketonuria Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Phenylketonuria Drug Market Size by Type
8.1.1 Asia Pacific Phenylketonuria Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Phenylketonuria Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Phenylketonuria Drug Market Size by Application
8.2.1 Asia Pacific Phenylketonuria Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Phenylketonuria Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Phenylketonuria Drug Market Size by Region
8.3.1 Asia Pacific Phenylketonuria Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Phenylketonuria Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Phenylketonuria Drug Market Size by Type
9.1.1 Latin America Phenylketonuria Drug Sales by Type (2017-2028)
9.1.2 Latin America Phenylketonuria Drug Revenue by Type (2017-2028)
9.2 Latin America Phenylketonuria Drug Market Size by Application
9.2.1 Latin America Phenylketonuria Drug Sales by Application (2017-2028)
9.2.2 Latin America Phenylketonuria Drug Revenue by Application (2017-2028)
9.3 Latin America Phenylketonuria Drug Market Size by Country
9.3.1 Latin America Phenylketonuria Drug Sales by Country (2017-2028)
9.3.2 Latin America Phenylketonuria Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Phenylketonuria Drug Market Size by Type
10.1.1 Middle East and Africa Phenylketonuria Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Phenylketonuria Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Phenylketonuria Drug Market Size by Application
10.2.1 Middle East and Africa Phenylketonuria Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Phenylketonuria Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Phenylketonuria Drug Market Size by Country
10.3.1 Middle East and Africa Phenylketonuria Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Phenylketonuria Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Biomarin
11.1.1 Biomarin Corporation Information
11.1.2 Biomarin Overview
11.1.3 Biomarin Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Biomarin Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biomarin Recent Developments
11.2 Vitaflo
11.2.1 Vitaflo Corporation Information
11.2.2 Vitaflo Overview
11.2.3 Vitaflo Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vitaflo Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vitaflo Recent Developments
11.3 Mead Johnson
11.3.1 Mead Johnson Corporation Information
11.3.2 Mead Johnson Overview
11.3.3 Mead Johnson Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mead Johnson Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mead Johnson Recent Developments
11.4 Nutricia
11.4.1 Nutricia Corporation Information
11.4.2 Nutricia Overview
11.4.3 Nutricia Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nutricia Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nutricia Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Overview
11.5.3 Abbott Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abbott Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Recent Developments
11.6 Dr. Schar
11.6.1 Dr. Schar Corporation Information
11.6.2 Dr. Schar Overview
11.6.3 Dr. Schar Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dr. Schar Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr. Schar Recent Developments
11.7 Prominmetabolics
11.7.1 Prominmetabolics Corporation Information
11.7.2 Prominmetabolics Overview
11.7.3 Prominmetabolics Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Prominmetabolics Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Prominmetabolics Recent Developments
11.8 Cambrooke
11.8.1 Cambrooke Corporation Information
11.8.2 Cambrooke Overview
11.8.3 Cambrooke Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cambrooke Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cambrooke Recent Developments
11.9 Juvela
11.9.1 Juvela Corporation Information
11.9.2 Juvela Overview
11.9.3 Juvela Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Juvela Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Juvela Recent Developments
11.10 Firstplay Dietary
11.10.1 Firstplay Dietary Corporation Information
11.10.2 Firstplay Dietary Overview
11.10.3 Firstplay Dietary Phenylketonuria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Firstplay Dietary Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Firstplay Dietary Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Phenylketonuria Drug Industry Chain Analysis
12.2 Phenylketonuria Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Phenylketonuria Drug Production Mode & Process
12.4 Phenylketonuria Drug Sales and Marketing
12.4.1 Phenylketonuria Drug Sales Channels
12.4.2 Phenylketonuria Drug Distributors
12.5 Phenylketonuria Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Phenylketonuria Drug Industry Trends
13.2 Phenylketonuria Drug Market Drivers
13.3 Phenylketonuria Drug Market Challenges
13.4 Phenylketonuria Drug Market Restraints
14 Key Findings in The Global Phenylketonuria Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Phenylketonuria Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Medications
Table 3. Major Manufacturers of Supplements
Table 4. Major Manufacturers of Others
Table 5. Global Phenylketonuria Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Phenylketonuria Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Phenylketonuria Drug Sales by Region (2017-2022) & (K Pcs)
Table 8. Global Phenylketonuria Drug Sales Market Share by Region (2017-2022)
Table 9. Global Phenylketonuria Drug Sales by Region (2023-2028) & (K Pcs)
Table 10. Global Phenylketonuria Drug Sales Market Share by Region (2023-2028)
Table 11. Global Phenylketonuria Drug Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Phenylketonuria Drug Revenue Market Share by Region (2017-2022)
Table 13. Global Phenylketonuria Drug Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Phenylketonuria Drug Revenue Market Share by Region (2023-2028)
Table 15. Global Phenylketonuria Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 16. Global Phenylketonuria Drug Sales Share by Manufacturers (2017-2022)
Table 17. Global Phenylketonuria Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Phenylketonuria Drug Revenue Share by Manufacturers (2017-2022)
Table 19. Phenylketonuria Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 20. Global Phenylketonuria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Phenylketonuria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylketonuria Drug as of 2021)
Table 22. Phenylketonuria Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Phenylketonuria Drug Product Offered
Table 24. Date of Manufacturers Enter into Phenylketonuria Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Phenylketonuria Drug Sales by Type (2017-2022) & (K Pcs)
Table 27. Global Phenylketonuria Drug Sales by Type (2023-2028) & (K Pcs)
Table 28. Global Phenylketonuria Drug Sales Share by Type (2017-2022)
Table 29. Global Phenylketonuria Drug Sales Share by Type (2023-2028)
Table 30. Global Phenylketonuria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Phenylketonuria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Phenylketonuria Drug Revenue Share by Type (2017-2022)
Table 33. Global Phenylketonuria Drug Revenue Share by Type (2023-2028)
Table 34. Phenylketonuria Drug Price by Type (2017-2022) & (USD/Pcs)
Table 35. Global Phenylketonuria Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 36. Global Phenylketonuria Drug Sales by Application (2017-2022) & (K Pcs)
Table 37. Global Phenylketonuria Drug Sales by Application (2023-2028) & (K Pcs)
Table 38. Global Phenylketonuria Drug Sales Share by Application (2017-2022)
Table 39. Global Phenylketonuria Drug Sales Share by Application (2023-2028)
Table 40. Global Phenylketonuria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Phenylketonuria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Phenylketonuria Drug Revenue Share by Application (2017-2022)
Table 43. Global Phenylketonuria Drug Revenue Share by Application (2023-2028)
Table 44. Phenylketonuria Drug Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global Phenylketonuria Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 46. North America Phenylketonuria Drug Sales by Type (2017-2022) & (K Pcs)
Table 47. North America Phenylketonuria Drug Sales by Type (2023-2028) & (K Pcs)
Table 48. North America Phenylketonuria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Phenylketonuria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Phenylketonuria Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. North America Phenylketonuria Drug Sales by Application (2023-2028) & (K Pcs)
Table 52. North America Phenylketonuria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Phenylketonuria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Phenylketonuria Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. North America Phenylketonuria Drug Sales by Country (2023-2028) & (K Pcs)
Table 56. North America Phenylketonuria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Phenylketonuria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Phenylketonuria Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Phenylketonuria Drug Sales by Type (2023-2028) & (K Pcs)
Table 60. Europe Phenylketonuria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Phenylketonuria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Phenylketonuria Drug Sales by Application (2017-2022) & (K Pcs)
Table 63. Europe Phenylketonuria Drug Sales by Application (2023-2028) & (K Pcs)
Table 64. Europe Phenylketonuria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Phenylketonuria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Phenylketonuria Drug Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Phenylketonuria Drug Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Phenylketonuria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Phenylketonuria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Phenylketonuria Drug Sales by Type (2017-2022) & (K Pcs)
Table 71. Asia Pacific Phenylketonuria Drug Sales by Type (2023-2028) & (K Pcs)
Table 72. Asia Pacific Phenylketonuria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Phenylketonuria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Phenylketonuria Drug Sales by Application (2017-2022) & (K Pcs)
Table 75. Asia Pacific Phenylketonuria Drug Sales by Application (2023-2028) & (K Pcs)
Table 76. Asia Pacific Phenylketonuria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Phenylketonuria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Phenylketonuria Drug Sales by Region (2017-2022) & (K Pcs)
Table 79. Asia Pacific Phenylketonuria Drug Sales by Region (2023-2028) & (K Pcs)
Table 80. Asia Pacific Phenylketonuria Drug Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Phenylketonuria Drug Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Phenylketonuria Drug Sales by Type (2017-2022) & (K Pcs)
Table 83. Latin America Phenylketonuria Drug Sales by Type (2023-2028) & (K Pcs)
Table 84. Latin America Phenylketonuria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Phenylketonuria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Phenylketonuria Drug Sales by Application (2017-2022) & (K Pcs)
Table 87. Latin America Phenylketonuria Drug Sales by Application (2023-2028) & (K Pcs)
Table 88. Latin America Phenylketonuria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Phenylketonuria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Phenylketonuria Drug Sales by Country (2017-2022) & (K Pcs)
Table 91. Latin America Phenylketonuria Drug Sales by Country (2023-2028) & (K Pcs)
Table 92. Latin America Phenylketonuria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Phenylketonuria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Phenylketonuria Drug Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East and Africa Phenylketonuria Drug Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East and Africa Phenylketonuria Drug Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Phenylketonuria Drug Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Phenylketonuria Drug Sales by Application (2017-2022) & (K Pcs)
Table 99. Middle East and Africa Phenylketonuria Drug Sales by Application (2023-2028) & (K Pcs)
Table 100. Middle East and Africa Phenylketonuria Drug Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Phenylketonuria Drug Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Phenylketonuria Drug Sales by Country (2017-2022) & (K Pcs)
Table 103. Middle East and Africa Phenylketonuria Drug Sales by Country (2023-2028) & (K Pcs)
Table 104. Middle East and Africa Phenylketonuria Drug Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Phenylketonuria Drug Revenue by Country (2023-2028) & (US$ Million)
Table 106. Biomarin Corporation Information
Table 107. Biomarin Description and Major Businesses
Table 108. Biomarin Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 109. Biomarin Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Biomarin Recent Developments
Table 111. Vitaflo Corporation Information
Table 112. Vitaflo Description and Major Businesses
Table 113. Vitaflo Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. Vitaflo Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Vitaflo Recent Developments
Table 116. Mead Johnson Corporation Information
Table 117. Mead Johnson Description and Major Businesses
Table 118. Mead Johnson Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 119. Mead Johnson Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Mead Johnson Recent Developments
Table 121. Nutricia Corporation Information
Table 122. Nutricia Description and Major Businesses
Table 123. Nutricia Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 124. Nutricia Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Nutricia Recent Developments
Table 126. Abbott Corporation Information
Table 127. Abbott Description and Major Businesses
Table 128. Abbott Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 129. Abbott Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Abbott Recent Developments
Table 131. Dr. Schar Corporation Information
Table 132. Dr. Schar Description and Major Businesses
Table 133. Dr. Schar Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 134. Dr. Schar Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Dr. Schar Recent Developments
Table 136. Prominmetabolics Corporation Information
Table 137. Prominmetabolics Description and Major Businesses
Table 138. Prominmetabolics Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Prominmetabolics Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Prominmetabolics Recent Developments
Table 141. Cambrooke Corporation Information
Table 142. Cambrooke Description and Major Businesses
Table 143. Cambrooke Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 144. Cambrooke Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Cambrooke Recent Developments
Table 146. Juvela Corporation Information
Table 147. Juvela Description and Major Businesses
Table 148. Juvela Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 149. Juvela Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Juvela Recent Developments
Table 151. Firstplay Dietary Corporation Information
Table 152. Firstplay Dietary Description and Major Businesses
Table 153. Firstplay Dietary Phenylketonuria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 154. Firstplay Dietary Phenylketonuria Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Firstplay Dietary Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Phenylketonuria Drug Distributors List
Table 159. Phenylketonuria Drug Customers List
Table 160. Phenylketonuria Drug Market Trends
Table 161. Phenylketonuria Drug Market Drivers
Table 162. Phenylketonuria Drug Market Challenges
Table 163. Phenylketonuria Drug Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Phenylketonuria Drug Product Picture
Figure 3. Global Phenylketonuria Drug Market Share by Type in 2021 & 2028
Figure 3. Medications Product Picture
Figure 4. Supplements Product Picture
Figure 5. Others Product Picture
Figure 6. Global Phenylketonuria Drug Market Share by Application in 2021 & 2028
Figure 7. Household
Figure 8. Hospital
Figure 9. Others
Figure 10. Phenylketonuria Drug Report Years Considered
Figure 11. Global Phenylketonuria Drug Sales 2017-2028 (K Pcs)
Figure 12. Global Phenylketonuria Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Phenylketonuria Drug Revenue 2017-2028 (US$ Million)
Figure 14. Global Phenylketonuria Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Phenylketonuria Drug Sales Market Share by Region (2017-2022)
Figure 16. Global Phenylketonuria Drug Sales Market Share by Region (2023-2028)
Figure 17. North America Phenylketonuria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 18. North America Phenylketonuria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Phenylketonuria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 20. Europe Phenylketonuria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Phenylketonuria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 22. Asia-Pacific Phenylketonuria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Phenylketonuria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 24. Latin America Phenylketonuria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Phenylketonuria Drug Sales YoY (2017-2028) & (K Pcs)
Figure 26. Middle East & Africa Phenylketonuria Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Phenylketonuria Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Phenylketonuria Drug in the World: Market Share by Phenylketonuria Drug Revenue in 2021
Figure 29. Global Phenylketonuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Phenylketonuria Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Phenylketonuria Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
Figure 34. North America Phenylketonuria Drug Sales Market Share by Type (2017-2028)
Figure 35. North America Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
Figure 36. North America Phenylketonuria Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
Figure 38. North America Phenylketonuria Drug Sales Share by Country (2017-2028)
Figure 39. North America Phenylketonuria Drug Revenue Share by Country (2017-2028)
Figure 40. U.S. Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Phenylketonuria Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
Figure 44. Europe Phenylketonuria Drug Sales Market Share by Application (2017-2028)
Figure 45. Europe Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
Figure 46. Europe Phenylketonuria Drug Sales Share by Country (2017-2028)
Figure 47. Europe Phenylketonuria Drug Revenue Share by Country (2017-2028)
Figure 48. Germany Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 49. France Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Phenylketonuria Drug Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Phenylketonuria Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Phenylketonuria Drug Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Phenylketonuria Drug Revenue Share by Region (2017-2028)
Figure 59. China Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 62. India Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Phenylketonuria Drug Sales Market Share by Type (2017-2028)
Figure 70. Latin America Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Phenylketonuria Drug Sales Market Share by Application (2017-2028)
Figure 72. Latin America Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Phenylketonuria Drug Sales Share by Country (2017-2028)
Figure 74. Latin America Phenylketonuria Drug Revenue Share by Country (2017-2028)
Figure 75. Mexico Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Phenylketonuria Drug Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Phenylketonuria Drug Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Phenylketonuria Drug Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Phenylketonuria Drug Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Phenylketonuria Drug Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Phenylketonuria Drug Revenue Share by Country (2017-2028)
Figure 84. Turkey Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Phenylketonuria Drug Revenue (2017-2028) & (US$ Million)
Figure 87. Phenylketonuria Drug Value Chain
Figure 88. Phenylketonuria Drug Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed